CRISPR Patent Fight Between UC Berkeley, Broad Flares Up as USPTO Initiates New Interference

Jun 25, 2019

|

This article has been updated to add a comment from ERS Genomics CEO Eric Rhodes.

NEW YORK – The United States Patent and Trademark Office yesterday initiated a new patent interference in the CRISPR patent battle between the Broad Institute and the University of California, Berkeley.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Little More Regulation Wanted

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Medical Test for Tax Reasons

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Act Proposed to Combat Interference

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

PLOS Studies Examine Genes Co-Expressed in Depression, More

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.

Menu